P21 vs PE-22-28 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
P21 is a synthetic peptide derived from ciliary neurotrophic factor (CNTF), designed to promote neurogenesis - the formation of new neurons - in the hippocampus and olfactory bulb. CNTF is a potent neurotrophic factor but has poor CNS penetration and causes significant systemic s...
Calculate P21 dose →PE-22-28 is a synthetic fragment of spadin (a naturally occurring peptide derived from the NTSR3/sortilin propeptide) that antagonizes TREK-1, a two-pore domain potassium channel (K2P channel) that regulates neuronal excitability. TREK-1 is strongly implicated in depression and c...
Calculate PE-22-28 dose →| Parameter | P21 | PE-22-28 |
|---|---|---|
| Category | Cognitive & Neurological | Cognitive & Neurological |
| Research | Preclinical | Preclinical |
| Half-Life | - | - |
| Typical Dose | 100 µg/day | 100–200 µg |
| Frequency | Daily | Daily |
| Route | Subcutaneous / Intranasal | Subcutaneous / Intranasal |
| FDA Status | Not Approved | Not Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.